199
Views
0
CrossRef citations to date
0
Altmetric
Real-World Evidence

Extemporaneous combination therapy with nebivolol/valsartan for the treatment of hypertension: a study of real-world evidence in Europe

, , ORCID Icon, , , , & show all
Pages 1211-1219 | Received 27 Nov 2023, Accepted 20 May 2024, Published online: 03 Jun 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.